AS
AMITAVA SAHA Dirigeant
Other
IN IN · SEBI (PIT + SAST)
Discover the detailed record of transactions filed by AMITAVA SAHA, Dirigeant. Director active across 1 companies, notably Biocon Limited. In total, 21 disclosures have been logged. The latest transaction was disclosed on 10 January 2023 — Purchase. Regulator: SEBI (PIT + SAST). All data is openly available.
Declarations 21 total
€116,645 40,000 shares @ €2.9161
Equity Shares
SEBI:7b1b52323fd8a7c0ec55fc76b1840be2230c433e · 10 Jan 2023
Ideal exit: 7 Oct 2023 (T+270) €84,206 27,500 shares @ €3.062
Equity Shares
SEBI:486d8a7f82280dbf5c3a95d2eb2537b6b8bc262a · 21 Dec 2022
€84,206 27,500 shares @ €3.062
Equity Shares
SEBI:b53d71510312d88d9176452c18b345cac3b6450d · 21 Dec 2022
Ideal exit: 17 Sept 2023 (T+270) €6,640 2,000 shares @ €3.3201
Equity Shares
SEBI:eb48a595aa3e14f167251deaeb55b2a4477a0e6e · 1 Dec 2022
€3,315 1,000 shares @ €3.3147
Equity Shares
SEBI:ac3a6a7c9b55fe30325c401d7f945a9b8224295f · 2 Dec 2022
€4,194 1,000 shares @ €4.1936
Equity Shares
SEBI:feecaaaab1471e62d44d01ea40fff3cb831241f3 · 18 May 2022
€4,090 1,000 shares @ €4.0903
Equity Shares
SEBI:7b265b79bbe865ef0461cafe682f14fbd8ff9689 · 20 May 2022
€8,079 2,000 shares @ €4.0394
Equity Shares
SEBI:6362e7b05b56f01fbbaa323a3ced69ea87566ab6 · 12 May 2022
€22,573 5,000 shares @ €4.5146
Equity Shares
SEBI:8fb710bedad1aea547b131c2e2cddd32c28ee821 · 5 May 2022
€17,607 10,000 shares @ €1.7607
Equity Shares
SEBI:81dfcb24b6bdd5c13f38ad4a41ea482a53f2eebd · 5 May 2022
€39,290 10,000 shares @ €3.929
Equity Shares
SEBI:c7930211b9affe5f00fd6145de355b97862a1f4d · 19 Mar 2022
€22,230 5,000 shares @ €4.446
Equity Shares
SEBI:ba5e040e5cffa7929e5fc55eeb1eb3ed20b5b1de · 17 Nov 2021
€21,049 5,000 shares @ €4.2098
Equity Shares
SEBI:e51d152a1f53185ac08f28bd025b5284a94635d6 · 15 Nov 2021
€40,768 10,000 shares @ €4.0768
Equity Shares
SEBI:084d85635fbd8d44a452489083b21258b4c5b92a · 9 Nov 2021
€80,459 20,000 shares @ €4.0229
Equity Shares
SEBI:77605cd0e1cd53b280e3753d5537a961afbd64dd · 3 Nov 2021
€29,637 7,025 shares @ €4.2188
Equity Shares
SEBI:5cf6fd5cbe1fa44224a1a2f06b2720fd6f81f8cd · 29 Sept 2021
€231,055 56,000 shares @ €4.126
Equity Shares
SEBI:16b0b3eca704835f2752dbfaa424fe1cecfdcb25 · 27 Sept 2021
Ideal exit: 24 Jun 2022 (T+270) €12,759 3,000 shares @ €4.2529
Equity Shares
SEBI:6f58a8c11abb244ad957e59dec2b80700cf14603 · 22 Sept 2021
€23,656 5,925 shares @ €3.9926 0.0000% mcap 40.8% of flow
Equity Shares
SEBI:0143ff6da4b9a1239901f9f5c2659c1a55dc4c69 · 25 Aug 2021
Ideal exit: 22 May 2022 (T+270) €17,315 4,075 shares @ €4.249 0.0000% mcap 29.9% of flow
Equity Shares
SEBI:21a4b84353bb87e176463172132d0115604b679f · 20 Aug 2021
Ideal exit: 17 May 2022 (T+270) €16,995 4,075 shares @ €4.1705 0.0000% mcap 29.3% of flow
Equity Shares
SEBI:843de72091a0c876e53c7879783c7b5f7d52c223 · 20 Aug 2021
About AMITAVA SAHA Amitava Saha is an executive at Biocon Limited, a leading biopharmaceutical company. He is responsible for managing operations and developing new products. With his expertise in research and development, Amitava contributes to the innovation and quality of the products offered by Biocon. His commitment to operational excellence is essential to meet customer expectations.